{"name":"Phoenix Tissue Repair, Inc.","slug":"phoenix-tissue-repair-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOSXFtMjZydGRoRmdIaF8tSEFCRnBNQV93LUhvVlJNY09USTFaWjhVY3dPbXowRm5OWUp4WjBaZnJiQ1gxbG5RT1hqZTVfUDMxNjZRWFRmMnd4TGh4ZXlMaC1OWC1sallOal9Bc1c4VmpzelhDelVXNUZXUThKTEpDaE84V3c1OFVuNnFVYVp1dUdzeVFZdHZyeDRxNHUwc1Mw?oc=5","date":"2026-04-07","type":"pipeline","source":"openPR.com","summary":"Dystrophic Epidermolysis Bullosa Market Size in the 7MM was ~USD - openPR.com","headline":"Dystrophic Epidermolysis Bullosa Market Size in the 7MM was ~USD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxQTzhXZ0t1NWJaeHRsS1BiLTZNWk96cUtXNmNUeThueEwyaDVCbk95aFZZZ0JqazV1SEg0YkpjRjEySjAwT1hOMS1xa3NYb2VuWlVjVlpUT0dtWGp0TXlaZ285V3ZUVzdnMzdybk5TQlFYWUw2ZFZRaFRHZE5UMmZrQWpUU05HUUV4YVdCUUZZdldfR0YxVzVreHVqMVM4TF9CWV9acHRKQUhMOHhRaEZ5bzA2NTRvU2xWcmdaOVpCcXppMl9CMHhPbjVwWVhvWU0xZ29kUnpHSU5uYnZoa0pnNlc0LURDVkhIM2NxUlF3UUtteWZXZ1ZmZS1ZYWdxNlA1MzdFSXU4bWlPeG11SlZNUW1maUtZNWJvZVBCYTVRdC1lODNYNVE?oc=5","date":"2026-03-17","type":"pipeline","source":"prnewswire.com","summary":"Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight - prnewswire.com","headline":"Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPTGFlNmx0T2ZSSXpIclNPMjdnLVUxX3JkUHB1REtfbzdhcktLbkI5X3pVT0NWYXFKSGNFT1g5alRCNTlXOUs4R040V28tTXZrNXNrVzROYlFTTUtsMDQweldLYnY3cEZ2eU16ZjdkWnJmcENhaURsVTZ0MlJoYWpWd3lMdlMtR0thY3BpZEVaV3JWdFpWSm81ZjhUdnZSaEhyTDFDdjdzNF9pMC1IcmlZQjcwcWJxRTlsY2M0NHE1TUlxVDNPMDZ3RklpcjRCMHNRVnF5VzQzR3BUVWNyZF9JWUhyc210TzR6YzZjakp6cE9vRzIxOVRNWlVR?oc=5","date":"2025-05-22","type":"regulatory","source":"prnewswire.com","summary":"ZEVASKYN Approval Positions Abeona as Emerging Player in Dystrophic Epidermolysis Bullosa Market | DelveInsight - prnewswire.com","headline":"ZEVASKYN Approval Positions Abeona as Emerging Player in Dystrophic Epidermolysis Bullosa Market | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPLUZVVHFOa1FFVFdkNlp0YTNHRktsajBVdnpfdDU5Qjk5eGwxRUFIbG9uVG82eG1qOGV1WDdJNjRpc0FtUVNQZGhwRnRSSFp5UnI1Nnh0Z3E5QnFQc2VIMmdmdUNFa3FhNXVkSXlPdkY0TDhIeGlZZWJNS1MxSDlsV3JQQ3U3MF9iOVNMdG82MXJ3eXhhNmVBZG5KNjUxNE1TMHBTZ2YwdDF2S0l3SGc?oc=5","date":"2022-08-02","type":"pipeline","source":"BioSpace","summary":"Dystrophic Epidermolysis Bullosa Treatment Market Size to Hit US$ 715 Million by 2030 - BioSpace","headline":"Dystrophic Epidermolysis Bullosa Treatment Market Size to Hit US$ 715 Million by 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNOS1Ud1gtVzRCMVJxOFRGR3FPMVl2dDRBbDN5bnY0Z3dfcnhOQVBMZXZ5ZzRCSk9fa3doUENyLTE1TDNXdnFmVTZsMnUxSVAxZUlwRDZ2Zk5ic3V3TnRyMEdsWFlPV3JNTzdrNXpnRjhXY2NYWE9YZ3kwQWlxN2Q1amh3M2J0TldHMHlBREJRbFR0UlU0LTJnWWFEdXE3dUVRNUlvcEUzYw?oc=5","date":"2022-05-20","type":"trial","source":"BioSpace","summary":"BridgeBio Continues Comeback with Positive Epidermolysis Bullosa Data - BioSpace","headline":"BridgeBio Continues Comeback with Positive Epidermolysis Bullosa Data","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNYkZCQUpHc2I3VGlueFBHUlhBNXZ6dDZPX1BfSXc4YlkzTW9uRkpndVFWU3RhWGxQRklsaVBIdFo4c2UzMUI3blpnYXhKbU9VMzZsbE1Eclh0MTRkTnNjYlRKMWg5bjFpOXRJeGctdjk2TVJCNHFhcmtSRFBpZVU0YXRndU1rZEZPck1jNmVyYw?oc=5","date":"2022-03-28","type":"trial","source":"Stanford Medicine","summary":"Gene-therapy gel shows promise for blistering skin disease in clinical trial - Stanford Medicine","headline":"Gene-therapy gel shows promise for blistering skin disease in clinical trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}